SonoSite, Inc. (NASDAQ:SONO)
CAPS Rating:
The Company deales in the development of HCU systems for use in a variety of medical specialties in a range of clinical settings.
The Official Website of the Long-Term Investor
The Company deales in the development of HCU systems for use in a variety of medical specialties in a range of clinical settings.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
This stock is a bit risky. Most analysts predict great things for SONO's profits, but a few are fearful over its two patent infringement lawsuits. Nevertheless, consensus estimates are for eps growth of over 100% in 08 and close to 70% in 09. Long term growth is estimated at 75%/year for 3 to 5 years. Yet SONO is selling today (3/6/08) at only 21 x 09 earnings, a bargain. Even more remarkable, Morningstar calculates that SONO's PEG (price earnings to growth) ratio is only .3, which is extraordinarily low for any stock, particularly one in the medical world. If one is willing to accept a bit of legal risk, this stock could produce substantial returns. Looking at the odds, it might be a very good bet...